Product Description
Tacrosyn 0.5 Mg Capsules, manufactured by Synokem Pharmaceuticals Ltd. and marketed by Zydus Healthcare, represent a radiant new release in immunosuppressive therapy. These first-string, meritorious capsules are specifically formulated with tacrolimus, offering competitive pricing and tangible savings for organ transplant recipients. Designed as an oral, allopathic medication for prophylaxis of kidney, liver, or heart transplant rejection, Tacrosyn stands out for its high efficacy and strict adherence to safety standards. Supplied in white/yellowish capsules, each blister strip contains 10 capsules, ensuring convenience and precise dosing under physician supervision. Prescription only. Store below 25C.
Tacrosyn 0.5 Mg Capsules: Trusted Protection for Transplant Patients
Tacrosyn 0.5 Mg Capsules serve organ transplant patients seeking effective immunosuppressant therapy. Designed for adult recipients of kidney, liver, or heart transplants, these meritorious capsules help safeguard against organ rejection. Competitive pricing provides genuine savings for users and healthcare providers. Featuring a long shelf life of 24 months, user-friendly blister packs, and a precise 0.5 mg tacrolimus dosage per capsule, Tacrosyn offers a distinguished option for those needing continuous transplant care.
Transparent Sample Policy and Efficient Supply Chain for Tacrosyn
Our sample policy for Tacrosyn 0.5 Mg Capsules ensures that prospective partners are handed over product samples at the lowest price, minimizing initial expenditure. Samples are readily available for evaluation. The convenient FOB port facilitates seamless export-import processes, supporting timely delivery and reliable distribution worldwide. Bulk orders and small samples alike benefit from the same meritorious support and attention. Contact our sales team to inquire about specific distributor options, pricing, and sample arrangements.
FAQ's of Tacrosyn 0.5 Mg Capsules:
Q: How should Tacrosyn 0.5 Mg Capsules be administered for optimal effectiveness?
A: Tacrosyn 0.5 Mg Capsules should be taken orally, as prescribed by a registered medical practitioner. The capsules must not be crushed or chewed, and dosage adjustments depend on individual needs and physician guidance.
Q: What is the primary benefit of using Tacrosyn 0.5 Mg Capsules for transplant patients?
A: The primary benefit is the prevention of organ transplant rejection, ensuring the longevity and health of transplanted kidney, liver, or heart in adult patients through effective immunosuppressive action.
Q: Who can use Tacrosyn 0.5 Mg Capsules and is a prescription required?
A: Tacrosyn is suitable for adult patients who have undergone organ transplantation. It is a prescription-only medication and must be used under the supervision of a registered medical practitioner.
Q: When can I expect to receive sample capsules, and what is the process for requesting them?
A: Samples can usually be handed over promptly after your request and confirmation. Please contact our sales team with your requirements for further instructions on obtaining sample capsules.
Q: Where should Tacrosyn 0.5 Mg Capsules be stored to ensure maximum shelf life?
A: Store the capsules below 25C in a dry place, protected from light and moisture, to maintain their efficacy throughout the 24-month shelf life.
Q: What are the potential side effects of using Tacrosyn 0.5 Mg Capsules?
A: Possible side effects include tremors, headaches, hypertension, and nephrotoxicity. It is important to monitor regularly and report any unusual symptoms to your healthcare provider immediately.